|
|
Identification of optimum spectacle prescriptions for patients with Down syndrome |
| 5R01EY024590-08 |
|
NEI |
2022 |
|
|
Applications of high resolution fMRI in ultra-high field (7T) in revealing developmental disorders underlying amblyopia |
| 5R01EY030434-03 |
|
NEI |
2022 |
|
|
Acute Prenatal Alcohol Exposure Potentiates Conotruncal Defects in the Setting of a Permissive Genetic Background |
| 1F30AA029936-01A1 |
|
NIAAA |
2022 |
|
|
Simultaneous prenatal alcohol and cannabinoid exposure & offspring corticostriatal neurocircuitry |
| 1F32AA029866-01A1 |
|
NIAAA |
2022 |
|
|
Physical and Neurocognitive Outcomes Among Children with Fetal Alcohol Spectrum Disorder Outcomes (FASD): The Contribution of Maternal Nutrition and Nutrigenetic Risk Factors |
| 1F32AA030495-01 |
|
NIAAA |
2022 |
|
|
Consequences of combined prenatal alcohol exposure and acute placental ischemia on frontal cortical-sensitive behavior, structure, and physiology in juvenile offspring |
| 1K08AA030080-01 |
|
NIAAA |
2022 |
|
|
Mechanisms for predisposition to AUD following prenatal alcohol and THC comorbidity |
| 1K99AA029167-01A1 |
|
NIAAA |
2022 |
|
|
Role of Microglia in Prenatal ethanol exposure-induced Impairment of Endocannabinoid Signaling |
| 1R01AA028476-01A1 |
|
NIAAA |
2022 |
|
|
Neurodevelopmental Effects of Prenatal Exposure to Maternal Drinking, Smoking and Adverse Psychosocial Factors: Deep Phenotyping of Infant CNS and ANS Function |
| 1R01AA029159-01A1 |
|
NIAAA |
2022 |
|
|
Maternal mediators of fetal growth restriction linked to prenatal alcohol exposure |
| 1R01AA029594-01A1 |
|
NIAAA |
2022 |
